38-state cannabis study raises mental health screening question for DHA clinics

A 38-state US study published online on 26 August 2026 found that more frequent cannabis use was associated with fewer days of good mental health among adults aged 21 to 64, with the clearest signal among men.

For UAE operators, the finding is less about cannabis policy and more about intake quality. In Dubai, the Dubai Health Authority (DHA) licenses providers. In Abu Dhabi and Al Ain, the Department of Health Abu Dhabi (DOH) regulates providers. In Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain, the Ministry of Health and Prevention (MOHAP) is the relevant regulator. Clinics seeing anxiety, depression, sleep problems or recurrent panic symptoms should treat substance-use screening as a standard part of mental health assessment.

What the study found

The article, Cannabis Use and Individual Health Measures, was written by Weiwei Chen of Kennesaw State University and Michael T. French of the University of Miami. Mirage News reported the findings on 3 September 2026, citing data from the 2016-2023 Behavioral Risk Factor Surveillance System.

Chen and French tested cannabis-use frequency against self-reported overall, physical and mental health. The strongest model used average cannabis use within matched gender-age groups as an instrument. It found more cannabis-use days were linked to fewer good mental health days among users aged 21 to 64. For adults aged 65 and older, results were mixed and often statistically insignificant.

"We are presenting our findings without advocating for a particular policy or law."
Michael T. French, University of Miami Business School

The paper did not find a consistent relationship with physical health in either age group. The authors said that absence of a consistent physical-health result should not be read as proof of no physical risk.

Why UAE clinics and insurers should care

The UAE context is different. The official UAE portal states that the country has a zero-tolerance policy for recreational drug use, and cites Federal Decree-Law No. 30 of 2021 on narcotics and psychotropic substances. That legal backdrop makes disclosure harder. It also raises the value of careful clinical questioning, documented consent, and clear referral pathways when a patient reports use outside the UAE or past exposure.

For COOs, the operational issue is intake design. Mental health, family medicine, emergency and occupational health units should ask a short, consistent set of questions about substance exposure, sleep, panic attacks, self-harm risk and current medication. That can be built into triage templates within 30 days without buying a new system.

For CFOs and insurer relations teams, the question is avoidable utilisation. A missed substance-use history can turn a 50-minute therapy plan into repeat emergency visits, diagnostic imaging, sick leave paperwork and medication changes. Private UAE pricing varies by clinic and doctor grade. A practical budget check is:

• AED 400-900 for a 50-60 minute psychologist session in Dubai, according to the Zavis mental health cost guide.
• AED 600-1,200 for an initial psychiatrist consultation in Dubai, with lower follow-up fees often listed by clinics.
• Coverage for Daman, Thiqa, Sukoon and other UAE insurers is plan-specific, so clinics should verify network status, session limits and pre-authorisation before the first paid appointment.
• Patients paying cash should ask for written prices, session length, cancellation rules and whether reports for schools or employers carry a separate fee.

What operators should implement now

Medical directors should update clinical prompts rather than issue broad warnings. The useful question is specific: frequency of use, route, last use, country of use, reason for use, current symptoms and any prior psychosis, mania or self-harm. A patient who reports daily use and worsening anxiety needs a different care plan from a patient with remote exposure and stable symptoms.

CIOs should check whether EHR forms allow structured documentation of substance-use history without forcing clinicians into free-text notes. Structured fields help audits, referral triage and insurer documentation. They also reduce the risk that one clinician records "cannabis" while another records "THC" or "marijuana" with no searchable link between them.

For patients, the practical path is licensed care. Dubai residents should confirm DHA licensing, Abu Dhabi and Al Ain residents should check DOH licensing, and patients in the northern emirates should check MOHAP or Emirates Health Services routes where applicable. The UAE Open Healthcare Directory lists more than 12,386 licensed providers across eight UAE cities and includes a mental health category for finding licensed clinics, doctors and therapists.